REVIEW
Published on 16 Apr 2025
The partial clinical remission phase of type 1 diabetes: early-onset dyslipidemia, long-term complications, and disease-modifying therapies
doi 10.3389/fendo.2025.1462249
- 350 views
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Disease-modifying approaches in type 1 diabetes
Disease-modifying approaches in type 1 diabetes
8,405
Total downloads
30k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Accepted on 14 Mar 2025
Safety and efficacy of adjuvant Sotagliflozin therapy in patients with T1D -An Update and Systematic Review and Meta-Analysis
doi 10.3389/fendo.2025.1506652
- 238 views
MINI REVIEW
Published on 21 Jan 2025
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
doi 10.3389/fendo.2024.1520313
- 1,418 views
MINI REVIEW
Published on 15 Nov 2024
The role of GABA in type 1 diabetes
doi 10.3389/fendo.2024.1453396
- 2,647 views
- 2 citations
REVIEW
Published on 06 Nov 2024
Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
doi 10.3389/fendo.2024.1477101
- 2,204 views
- 2 citations
PERSPECTIVE
Published on 04 Oct 2024
A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging
doi 10.3389/fendo.2024.1476444
- 2,032 views
- 2 citations
ORIGINAL RESEARCH
Published on 30 Aug 2024
Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia
doi 10.3389/fendo.2024.1439351
- 1,580 views
- 2 citations
ORIGINAL RESEARCH
Published on 01 Aug 2024
Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations
doi 10.3389/fendo.2024.1419329
- 971 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Jul 2024
Prediction of personalised postprandial glycaemic response in type 1 diabetes mellitus
doi 10.3389/fendo.2024.1423303
- 1,748 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Feb 2024
Preserved C-peptide is common and associated with higher time in range in Chinese type 1 diabetes
doi 10.3389/fendo.2024.1335913
- 1,350 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Feb 2024
Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay
doi 10.3389/fendo.2024.1340436
- 1,765 views
- 2 citations
PERSPECTIVE
Published on 26 Jan 2024
Gene-environment interaction in the pathophysiology of type 1 diabetes
doi 10.3389/fendo.2024.1335435
- 4,742 views
- 10 citations
